Measurement of Alpha GST Release from 3D InSight™ Liver Microtissues

4 Apr 2016

This technical note details a protocol for determining injury to liver hepatocytes as measured through the release of alpha-GST. Hepatocytes contain high amounts of metabolic enzymes, which are released upon cellular injury into the cell culture supernatant. Beside the commonly used markers alanine aminotransferase (ALT) and aspartate aminotransferase (AST), alpha GST (αGST) is increasingly being used as a liver injury marker. αGST provides advantages as a biomarker for hepatotoxicity due to its high cytosolic concentration in hepatocytes and its rapid release upon their injury. Detection of alpha-GST release is therefore a specific and early indicator of hepatocyte injury.

3D InSight™ Human Liver Microtissues

InSphero

Discover the 3D InSight™ Human Liver Microtissues: the gold standard for Hepatotoxic screening. Pharma-validated co-culture models offer 2x higher DILI prediction sensitivity than 2D hepatocytes. Features pooled PHH from male/female donors co-cultured with Kupffer cells and LECs, 28-day viability, in 96-well format. Includes 50mL 3D InSight™ Liver Maintenance Medium. Check the bi-weekly production schedule online. 

(0)

Links

Tags